openPR Logo
Press release

Ulcerative Colitis Treatment Market Size Share Growth and Report 2023-2030

Ulcerative Colitis Treatment Market-DataM Intelligence

Ulcerative Colitis Treatment Market-DataM Intelligence

Global Ulcerative Colitis Treatment Market Sets to Expand, Projected to Reach US$ 11.1 Billion by 2030

The global ulcerative colitis treatment market, valued at US$ 6.9 billion in 2022, is poised for substantial growth, projected to attain US$ 11.1 billion by 2030. This growth is anticipated to be fueled by a robust compound annual growth rate (CAGR) of 6.3% during the forecast period from 2023 to 2030.

Market Dynamics Driving Growth

A surge in inflammatory bowel diseases, specifically ulcerative colitis, is contributing to the market's upward trajectory. Factors such as intensified research activities, a rise in product approvals, and notable market developments, including mergers, acquisitions, collaborations, and product introductions, are key drivers of the global ulcerative colitis treatment market.

Market Scope and Metrics

CAGR: 6.3%
Size Available for Years: 2021-2030
Forecast Period: 2023-2030
Data Availability: Value (US$)
Segments Covered: Type, Drug Class, Route of Administration, Distribution Channel, and Region
Regions Covered: North America, Europe, Asia-Pacific, South America, and Middle East & Africa

Download Sample: https://www.datamintelligence.com/download-sample/ulcerative-colitis-treatment-market

Market Insights and Analysis

Increasing Market Developments Boost Market Growth

Market developments, exemplified by Pfizer's acquisition of Arena Pharmaceuticals in March 2022, are expected to be a catalyst for market growth. This strategic move aimed to leverage Arena Pharmaceuticals' pipeline in conjunction with Pfizer's Immunology and swelling healing domain.

Research Activities Present Growth Opportunities

A surge in research activities, as seen with Takeda Pharmaceutical's phase III clinical investigation for intravenous Vedolizumab, is presenting substantial growth opportunities. The investigation aims to evaluate the effectiveness and safety of the drug in Japanese individuals with moderate to severe ulcerative colitis.

Stringent Regulatory Bodies Pose Challenges

However, the presence of stringent regulatory bodies, including the United States Food and Drug Administration (USFDA) and the European Medicines Agency, is anticipated to pose challenges for market growth during the forecast period.

Segment Analysis

Immunosuppressant Drug Class Dominates Market

The immunosuppressant drug class segment is estimated to dominate the global ulcerative colitis treatment market, holding approximately 39.6% of the market share. Bristol Myers Squibb's marketing authorization for Zeposia in November 2021 is a notable contributor to the segment's dominance.

Geographical Share

North America Holds Prominent Market Share

Owing to a high prevalence of inflammatory bowel diseases, North America is estimated to hold around 38.8% of the global market share by 2030. Pfizer's promising topline results from a Phase 3 investigation of stasimon further contribute to regional growth.

Key Market Players

The major global players in the ulcerative colitis treatment market include Abbott Laboratories, Ajinomoto, AstraZeneca Plc., Eli-Lilly, GlaxoSmithKline Plc., Index Pharmaceuticals Holdings AB, Johnson & Johnson, Merck & Co., Pfizer Inc., and Sanofi, among others.

For More Insights: https://www.datamintelligence.com/research-report/ulcerative-colitis-treatment-market

Market Segmentation

By Type:

Ulcerative Proctitis
Proctosigmoiditis
Left-sided Colitis
Pancolitis or Universal Colitis
Fulminant Colitis
By Drug Class:

Immunosuppressant
Anti-Inflammatory Drugs
Anti-TNF biologics
Calcineurin Inhibitors
Other
By Route of Administration:

Oral
Injectables
By Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Region:

North America
Europe
South America
Asia-Pacific
Middle East and Africa

Related Reports:

Achalasia Treatment Market: https://www.datamintelligence.com/research-report/achalasia-treatment-market

Esomeprazole Market: https://www.datamintelligence.com/research-report/esomeprazole-market

Antiemetic Drugs Market: https://www.datamintelligence.com/research-report/antiemetic-drugs-market

Contact Us -
Company Name: DataM Intelligence
Email: info@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence 4Market Research is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Ulcerative Colitis Treatment Market Size Share Growth and Report 2023-2030 here

News-ID: 3293417 • Views:

More Releases from DataM Intelligence 4Market Research

Acrylonitrile Market is expected to reach US$ 16.9 billion by 2030 | Major key players - Asahi Kasei Corporation, Formosa Plastics Corp., Formosa Plastics Corp.
Acrylonitrile Market is expected to reach US$ 16.9 billion by 2030 | Major key p …
Market Size and Growth: The Global Acrylonitrile Market size reached US$ 11.8 billion in 2022 and is expected to reach US$ 16.9 billion by 2030, growing with a CAGR of 4.7% during the forecast period 2024-2031. The Market is driven by rising demand for acrylic fibers, ABS resins, and nitrile rubber across automotive, construction, and consumer goods industries. According to DataM Intelligence Get a Free Sample Research PDF: https://datamintelligence.com/download-sample/acrylonitrile-market?sz The Acrylonitrile Market refers
Platinum Nickel Alloy Market is expected to reach US$ 1,330.0 million by 2030 | Top key players - Anglo Platinum, Sibanye-Stillwater, Norilsk Nickel.
Platinum Nickel Alloy Market is expected to reach US$ 1,330.0 million by 2030 | …
Market Size and Growth: The Global Platinum Nickel Alloy Market size reached US$ 777.5 million in 2022 and is expected to reach US$ 1,330.0 million by 2030, growing with a CAGR of 7.0% during the forecast period 2024-2031. The Market is growing due to rising demand for high-performance materials in electronics, aerospace, and automotive applications, driven by superior corrosion resistance and durability. According to DataM Intelligence Get a Free Sample Research PDF:
Fucoidan Market is expected to reach US$ 202.6 million by 2030 | Top key players - Kamerycah, Inc., Fucoidan Force, Haerim Fucoidan.
Fucoidan Market is expected to reach US$ 202.6 million by 2030 | Top key players …
Market Size and Growth: The Global Fucoidan Market size reached US$ 90.5 million in 2022 and is expected to reach US$ 202.6 million by 2030, growing with a CAGR of 10.6% during the forecast period 2024-2031. The Market is growing due to rising demand for natural bioactive ingredients in pharmaceuticals, nutraceuticals, and cosmetics owing to their anti-inflammatory and immune-boosting properties. According to DataM Intelligence Get a Free Sample Research PDF: https://datamintelligence.com/download-sample/fucoidan-market?sz The Fucoidan
Dimethylformamide Market is expected to reach US$ 2.8 billion by 2030 | Major key players - BASF SE, Eastman Chemical Company, Baxter International Inc.
Dimethylformamide Market is expected to reach US$ 2.8 billion by 2030 | Major ke …
Market Size and Growth: The Global Dimethylformamide (DMF) Market size reached US$ 2.1 billion in 2022 and is expected to reach US$ 2.8 billion by 2030, growing with a CAGR of 3.3% during the forecast period 2024-2031. The Market growth is driven by its rising use as a solvent in pharmaceuticals, synthetic leather, and chemical manufacturing industries. According to DataM Intelligence Get a Free Sample Research PDF: https://datamintelligence.com/download-sample/dimethylformamide-market?sz The Dimethylformamide (DMF) Market refers

All 5 Releases


More Releases for Colitis

Ulcerative Colitis Pipeline Insights Report | DelveInsight
DelveInsight's, "Ulcerative Colitis Pipeline Insight" report provides comprehensive insights about 70+ companies and 75+ pipeline drugs in Ulcerative Colitis Pipeline Landscape. It covers the Ulcerative Colitis pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Ulcerative Colitis therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Explore the comprehensive insights by DelveInsight and stay
Novel Therapies for Ulcerative Colitis Patients
"The Business Research Company recently released a comprehensive report on the Global Ulcerative Colitis Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry. According to The Business Research Company's, The ulcerative colitis market size
Ulcerative Colitis Market - Breaking Barriers, Transforming Digestive Health: Ul …
Newark, New Castle, USA: The "Ulcerative Colitis Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors Ulcerative Colitis Market: https://www.growthplusreports.com/report/ulcerative-colitis-market/8815 This latest report researches the industry structure, sales, revenue,
Ulcerative Colitis Market - Breaking Barriers, Empowering Resilience: Transformi …
Newark, New Castle, USA - new report, titled Ulcerative Colitis Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Ulcerative Colitis market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Ulcerative Colitis market. The report offers an overview of the market, which
Ulcerative Colitis - Drug Pipeline Landscape, 2023
Global Ulcerative Colitis Market report from Global Insight Services is the single authoritative source of intelligence on ulcerative colitis market. The report will provide you with analysis of impact of latest market disruptions such as Russia-Ukraine war and Covid-19 on the market. Report provides qualitative analysis of the market using various frameworks such as Porters' and PESTLE analysis. Report includes in-depth segmentation and market size data by categories, product types,
Ulcerative Colitis Market
Ulcerative colitis is the most common type of inflammatory bowel disease that affects the colon (lining of the large intestine) and rectum. The inflammation produces tiny sores called ulcers. These disease can affect people of any age, though prevalence is especially high among people under 30 years of age. The major symptoms of this disease are diarrhea, belly pain/cramps, bleeding from the rectum, also other indications are sudden and unexplained